SAR442257
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR442257, covering 2025-03-21 to 2025-03-21. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL [Phase 1]